ATE331502T1 - 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette - Google Patents

4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette

Info

Publication number
ATE331502T1
ATE331502T1 AT01949210T AT01949210T ATE331502T1 AT E331502 T1 ATE331502 T1 AT E331502T1 AT 01949210 T AT01949210 T AT 01949210T AT 01949210 T AT01949210 T AT 01949210T AT E331502 T1 ATE331502 T1 AT E331502T1
Authority
AT
Austria
Prior art keywords
hydroxybutylidene
amino
tablet containing
compressed tablet
direct compressed
Prior art date
Application number
AT01949210T
Other languages
English (en)
Inventor
Dagmar Jasprova
Original Assignee
Zentiva As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5471285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE331502(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zentiva As filed Critical Zentiva As
Application granted granted Critical
Publication of ATE331502T1 publication Critical patent/ATE331502T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
AT01949210T 2000-07-11 2001-06-29 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette ATE331502T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ20002567A CZ289261B6 (cs) 2000-07-11 2000-07-11 Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby

Publications (1)

Publication Number Publication Date
ATE331502T1 true ATE331502T1 (de) 2006-07-15

Family

ID=5471285

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01949210T ATE331502T1 (de) 2000-07-11 2001-06-29 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette

Country Status (17)

Country Link
US (1) US7198802B2 (de)
EP (1) EP1299088B1 (de)
AT (1) ATE331502T1 (de)
AU (1) AU2001270454A1 (de)
BG (1) BG107520A (de)
CA (1) CA2415630A1 (de)
CZ (1) CZ289261B6 (de)
DE (1) DE60121166D1 (de)
EE (1) EE200300017A (de)
HR (1) HRP20020735A2 (de)
HU (1) HUP0301072A3 (de)
PL (1) PL360872A1 (de)
RU (1) RU2279273C2 (de)
SK (1) SK283249B6 (de)
UA (1) UA73784C2 (de)
WO (1) WO2002003963A1 (de)
YU (1) YU77702A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6827718B2 (en) 2001-08-14 2004-12-07 Scimed Life Systems, Inc. Method of and apparatus for positioning and maintaining the position of endoscopic instruments
AU2003230805A1 (en) * 2002-04-05 2003-10-27 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
GR1004331B (el) * 2002-10-07 2003-09-05 Verisfield (Uk) Ltd Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας αλενδρονικου οξεος
WO2006018033A1 (en) * 2004-08-20 2006-02-23 Mepha Ag Formulations of bisphosphonates
WO2006046100A1 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Pharmaceutical composition of alendronic acid
WO2006054165A1 (en) * 2004-11-19 2006-05-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of alendronic acid and processes for their preparation
US9050391B2 (en) 2005-10-27 2015-06-09 Nexilis Ag Implant and production method for said implant
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
ES2476792T3 (es) * 2008-08-22 2014-07-15 Wockhardt Limited Composición farmacéutica de dosis oral unitaria única que comprende levodopa, carbidopa y entacapona o sales de las mismas
WO2010133629A1 (en) * 2009-05-19 2010-11-25 Grindeks, A Joint Stock Company Stable pharmaceutical composition of fludarabine phosphate
ES2453477T3 (es) 2009-12-18 2014-04-07 Frieslandcampina Nederland Holding B.V. Composición de excipiente coprocesada para un comprimido, su preparación y uso
WO2023025672A1 (en) 2021-08-25 2023-03-02 Basf Se Direct tableting auxiliary composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
BR9307859A (pt) * 1993-05-15 1996-01-09 Boehringer Mannheim Gmbh Comprimido com biodisponibilidade aperfeiçoada que contérn ácido
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
WO1998042379A2 (en) * 1997-03-26 1998-10-01 Sepracor Inc. Chemically and thermally stable norastemizole formulations
IL152082A0 (en) * 2000-04-07 2003-05-29 Pfizer Prod Inc Estrogen agonist/antagonist metabolites

Also Published As

Publication number Publication date
HRP20020735A2 (en) 2004-12-31
CZ20002567A3 (cs) 2001-12-12
US7198802B2 (en) 2007-04-03
DE60121166D1 (de) 2006-08-10
HUP0301072A2 (hu) 2003-08-28
CZ289261B6 (cs) 2001-12-12
UA73784C2 (en) 2005-09-15
RU2279273C2 (ru) 2006-07-10
US20030161878A1 (en) 2003-08-28
SK5112001A3 (en) 2002-02-05
AU2001270454A1 (en) 2002-01-21
WO2002003963A1 (en) 2002-01-17
SK283249B6 (sk) 2003-04-01
EE200300017A (et) 2004-10-15
BG107520A (bg) 2003-06-30
PL360872A1 (en) 2004-09-20
CA2415630A1 (en) 2002-01-17
YU77702A (sh) 2006-05-25
HUP0301072A3 (en) 2005-07-28
EP1299088A1 (de) 2003-04-09
EP1299088B1 (de) 2006-06-28

Similar Documents

Publication Publication Date Title
MY148680A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
NZ507271A (en) Fast disintegrating tablets
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
DE60142891D1 (de) Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung
DK0996429T3 (da) Faste opløsninger og faste dispersioner i vand tungtopløselige lægemidler
AR084101A2 (es) Comprimido de carga de droga alta y proceso para su preparacion
ATE331502T1 (de) 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette
ATE200733T1 (de) Pharmazeutische zubereitungen, die fluoxetin enthalten
PE20001036A1 (es) Tabletas bioadhesivas para hidratacion progresiva y metodos para su elaboracion y uso
EA200000584A3 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
WO2001072728A3 (en) Novel piperazine derivatives
PT1317419E (pt) Compostos e composições de ácido cianofenoxicarboxílico para administrar agentes activos
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
CA2326222A1 (en) Medicinal compositions
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
AU4249700A (en) Hydroxamic acid derivative
CA2326339A1 (en) Use of dexmedetomidine for icu sedation
RU2003102448A (ru) Таблетка, получаемая непосредственным прессованием, содержащая 4-амино-1-гидроксибутилиден-1,1-бисфосфоновую кислоту в качестве активного ингредиента
CA2311024A1 (en) Pharmaceutical composition for oral administration of chelating agents
EP1219296A4 (de) Mittel zur hemmung der sebumproduktion
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
EP0503079A4 (en) Pyridazinone-substituted ethynylphenyl derivative and remedy for circulatory organ disease containing the same as active ingredient
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
WO2002004012A8 (en) Anhydrous pharmaceutical composition of vancomycin for topical use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties